Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Clasificación en acciones #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Precio por acción
$2.49
Capitalización bursátil
$4.47M
Cambio (1 día)
-4.01%
Cambio (1 año)
678.16%
País
MY
Comercio BioNexus Gene Lab Corporation (BGLC)

Categoría

Ratio P/S de BioNexus Gene Lab Corporation (BGLC)
Ratio P/S al March 2026 TTM: 0.43
Según los informes financieros más recientes y el precio de las acciones de BioNexus Gene Lab Corporation, el ratio P/S actual (TTM) es 0.43. Al final de 2023, el ratio P/S era 0.93.
Historial del ratio P/S de BioNexus Gene Lab Corporation desde 2016 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 0.43 -18.23%
2024 0.52 -43.84%
2023 0.93 -93.79%
2022 15.03 -44.95%
2021 27.30 37.30%
2020 19.89 -98.67%
2019 1.50K 117.75%
2018 687.59 -54.92%
2017 1.53K 0.00%
2016 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
3.87 810.56%
US
5.39 1,168.02%
US
10.65 2,403.93%
US
5.22 1,127.52%
CN
4.46 949.91%
US